ClinicalTrials.gg
RecruitingNCT07466147Updated May 5, 2026

The Effect of Playful Physiotherapy Intervention

An interventional study of Playful physiotherapy programme in Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder, sponsored by University of Tartu. Recruiting at 1 site in Estonia. Open to participants aged 7 Years to 12 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-05.

Sponsored by University of Tartu · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
25
Allocation
Non-randomized
Ages
7 Years to 12 Years
Sex
All
01

Study summary

The goal of this quasi-experimental study is to evaluate the changes in emotional, behavioral, and psychosocial functioning of children aged 7-12 following a playful physiotherapy intervention. The study focused on the potential effects of a play- and body-based intervention on children's daily functioning, based on parent-reported assessments

The main question[s] it aims to answer [is/are]:

Participants will be evaluated based on the Strengths and Difficulties Questionnaire and KIDSCREEN-27 before and after the playful physiotherapy intervention programme.

02

Conditions studied

  • Attention Deficit Hyperactivity Disorder
  • Autism Spectrum Disorder
03

In context

Attention Deficit Disorder with Hyperactivity

1,817 studies on the registry are indexed under Attention Deficit Disorder with Hyperactivity; 296 are open to participants now.

This study's planned enrollment of 25 is below the median of 71 across 1,437 interventional studies indexed under Attention Deficit Disorder with Hyperactivity.

Browse Attention Deficit Disorder with Hyperactivity studies →

Lead sponsor

University of Tartu is the lead sponsor of 46 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 5-12 years;
  • Clinical diagnosis: ADHD, ASD, behavioral regulation difficulties, and/or social adaptation difficulties in group settings;
  • Participation in physiotherapy at ProVida Clinic or assessment by the clinic's rehabilitation team regarding suitability for participation;
  • Ability to participate in movement- and play-based activities in a group format;
  • Proficiency in Estonian;
  • No prior participation in a similar group.

Exclusion criteria

Exclusion Criteria:

  • Acute or chronic medical condition that prevents active participation;
  • Severe cognitive or sensory impairment that prevents understanding of activities or safe participation;
  • Situations in which the child's participation may disrupt group functioning or compromise safety.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
25 participants (estimated)

Study arms

  • Experimental
    Intervention group

    Other: Playful physiotherapy programme

  • No intervention
    Control group

Interventions

  • OtherPlayful physiotherapy programme

    Subjects will attend playful physiotherapy sessions

06

What researchers measure

Primary outcomes

  1. Quality of life of the participants

    Quality of life of the participants is evaluated by their parents using KIDSCREEN-27

    Time frame: Baseline and to the end of the intervention at 6 weeks

  2. Positive and negative aspects of psychosocial functioning of the participants

    Positive and negative aspects of participants' psychosocial functioning is evaluated bu their parents using SDQ scale.

    Time frame: Baseline and to the end of the intervention at 6 weeks

07

Study locations

1 of 1 sites recruiting
  • ProVida
    Tartu, Estonia
    Recruiting
    • Ingrid Tiirats · Contact
08

References and documents

Individual participant data

Plan to share: Undecided — IPD is considered to make available in the Open Science Foundation website.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07466147
Lead sponsor
University of Tartu
Responsible party
Hanna Kalajas-Tilga (PhD, University of Tartu) — Principal investigator
First posted
Mar 12, 2026
Start date
May 2026 (estimated)
Primary completion
Feb 2027 (estimated)
Completion
Feb 2027 (estimated)
Last update
May 5, 2026

Study contacts

Hanna Kalajas-Tilga, PhD
Contact
h9kala@gmail.com
+37258361041

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion